Ju-Whei Lee

2.2k total citations
20 papers, 1.4k citations indexed

About

Ju-Whei Lee is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ju-Whei Lee has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Ju-Whei Lee's work include Lung Cancer Treatments and Mutations (9 papers), Decision-Making and Behavioral Economics (4 papers) and Lung Cancer Research Studies (4 papers). Ju-Whei Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Decision-Making and Behavioral Economics (4 papers) and Lung Cancer Research Studies (4 papers). Ju-Whei Lee collaborates with scholars based in United States, Taiwan and Japan. Ju-Whei Lee's co-authors include J. Frank Yates, Hiromi Shinotsuka, Winston R. Sieck, Jill Kolesar, Andrea L. Patalano, Joan H. Schiller, Corey J. Langer, Barbara Burtness, Arlene A. Forastiere and Seena C. Aisner and has published in prestigious journals such as Journal of Clinical Oncology, Psychological Bulletin and Blood.

In The Last Decade

Ju-Whei Lee

20 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ju-Whei Lee United States	18	418	241	229	165	157	20	1.4k
Jennifer Garst United States	30	1.4k 3.4×	1.1k 4.6×	1.2k 5.4×	33 0.2×	335 2.1×	69	4.0k
David Gill United States	29	464 1.1×	347 1.4×	211 0.9×	43 0.3×	14 0.1×	107	2.9k
Ghulam Warsi United States	17	650 1.6×	215 0.9×	223 1.0×	28 0.2×	151 1.0×	36	2.4k
Karen Lee United States	24	555 1.3×	718 3.0×	248 1.1×	47 0.3×	20 0.1×	87	2.6k
Ian Fraser United Kingdom	25	225 0.5×	277 1.1×	162 0.7×	9 0.1×	14 0.1×	105	2.2k
Stephen P. Dunn United States	30	297 0.7×	179 0.7×	711 3.1×	51 0.3×	98 0.6×	179	3.0k
John James United States	26	91 0.2×	192 0.8×	193 0.8×	60 0.4×	119 0.8×	138	2.1k
Christian Jacques Canada	32	2.3k 5.6×	795 3.3×	1.0k 4.5×	85 0.5×	301 1.9×	111	4.7k
Frances Boyle Australia	34	1.7k 4.2×	665 2.8×	440 1.9×	79 0.5×	145 0.9×	191	3.5k
James A. Wolff United States	26	238 0.6×	434 1.8×	560 2.4×	201 1.2×	273 1.7×	99	2.8k

Countries citing papers authored by Ju-Whei Lee

Since Specialization

Citations

This map shows the geographic impact of Ju-Whei Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju-Whei Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju-Whei Lee more than expected).

Fields of papers citing papers by Ju-Whei Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju-Whei Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju-Whei Lee. The network helps show where Ju-Whei Lee may publish in the future.

Co-authorship network of co-authors of Ju-Whei Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Ju-Whei Lee. A scholar is included among the top collaborators of Ju-Whei Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju-Whei Lee. Ju-Whei Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Jyoti D., Ju-Whei Lee, David P. Carbone, et al.. (2020). Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508). Clinical Lung Cancer. 21(6). 520–526. 18 indexed citations

Lee, Ju-Whei, Dong‐Hua Yang, Fang Zhu, et al.. (2019). PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma. Oral Oncology. 91. 69–78. 28 indexed citations

Ganzel, Chezi, Judith Manola, Dan Douer, et al.. (2016). Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008. Journal of Clinical Oncology. 34(29). 3544–3553. 85 indexed citations

Baljević, Muhamed, Bogdan Dumitriu, Ju-Whei Lee, et al.. (2016). Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia. Acta Haematologica. 136(4). 210–218. 15 indexed citations

Luskin, Marlise R., Ju-Whei Lee, Hugo F. Fernández, et al.. (2016). Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups. Blood. 127(12). 1551–1558. 87 indexed citations

Psyrri, Amanda, Ju-Whei Lee, Eirini Pectasides, et al.. (2014). Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC: Eastern Cooperative Oncology Group E2303. Clinical Cancer Research. 20(11). 3023–3032. 24 indexed citations

Egloff, Ann Marie, Ju-Whei Lee, Corey J. Langer, et al.. (2014). Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303. Clinical Cancer Research. 20(19). 5041–5051. 26 indexed citations

Hamann, Heidi, Ju-Whei Lee, Joan H. Schiller, et al.. (2013). Clinician Perceptions of Care Difficulty, Quality of Life, and Symptom Reports for Lung Cancer Patients: An Analysis from the Symptom Outcomes and Practice Patterns (SOAPP) Study. Journal of Thoracic Oncology. 8(12). 1474–1483. 28 indexed citations

Argiris, Athanassios, Musie Ghebremichael, Jill Gilbert, et al.. (2013). Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial. Journal of Clinical Oncology. 31(11). 1405–1414. 147 indexed citations

10.

Fisch, Michael, Ju-Whei Lee, Matthias Weiss, et al.. (2012). Prospective, Observational Study of Pain and Analgesic Prescribing in Medical Oncology Outpatients With Breast, Colorectal, Lung, or Prostate Cancer. Journal of Clinical Oncology. 30(16). 1980–1988. 197 indexed citations

11.

Lee, Ju-Whei, Seena C. Aisner, Corey J. Langer, et al.. (2011). Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma. Journal of Clinical Oncology. 29(15). 2060–2065. 161 indexed citations

12.

Ramalingam, Suresh S., Ju-Whei Lee, Chandra P. Belani, et al.. (2011). Cetuximab for the Treatment of Advanced Bronchioloalveolar Carcinoma (BAC): An Eastern Cooperative Oncology Group Phase II Study (ECOG 1504). Journal of Clinical Oncology. 29(13). 1709–1714. 17 indexed citations

13.

Amann, Joseph M., Ju-Whei Lee, Heinrich Röder, et al.. (2010). Genetic and Proteomic Features Associated with Survival after Treatment with Erlotinib in First-Line Therapy of Non-small Cell Lung Cancer in Eastern Cooperative Oncology Group 3503. Journal of Thoracic Oncology. 5(2). 169–178. 49 indexed citations

14.

Yates, J. Frank, et al.. (2010). Indecisiveness and Culture: Incidence, Values, and Thoroughness. Journal of Cross-Cultural Psychology. 41(3). 428–444. 38 indexed citations

15.

Traynor, Anne M., Ju-Whei Lee, Sachdev Thomas, et al.. (2009). A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503. Investigational New Drugs. 28(1). 91–97. 101 indexed citations

16.

Chen, Heidi, Shuo Chen, Roy S. Herbst, et al.. (2009). Classification by Mass Spectrometry Can Accurately and Reliably Predict Outcome in Patients with Non-small Cell Lung Cancer Treated with Erlotinib-Containing Regimen. Journal of Thoracic Oncology. 4(6). 689–696. 23 indexed citations

17.

Yates, J. Frank, Ju-Whei Lee, Hiromi Shinotsuka, Andrea L. Patalano, & Winston R. Sieck. (1998). Cross-Cultural Variations in Probability Judgment Accuracy: Beyond General Knowledge Overconfidence?. Organizational Behavior and Human Decision Processes. 74(2). 89–117. 143 indexed citations

18.

Yates, J. Frank, Ju-Whei Lee, & Hiromi Shinotsuka. (1996). Beliefs about Overconfidence, Including Its Cross-National Variation. Organizational Behavior and Human Decision Processes. 65(2). 138–147. 120 indexed citations

19.

Yates, J. Frank, Paul C. Price, Ju-Whei Lee, & James Ramirez. (1996). Good probabilistic forecasters: The ‘consumer's’ perspective. International Journal of Forecasting. 12(1). 41–56. 66 indexed citations

20.

Lee, Ju-Whei & J. Frank Yates. (1992). How quantity judgment changes as the number of cues increases: An analytical framework and review.. Psychological Bulletin. 112(2). 363–377. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact